Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
23.96
-1.19 (-4.73%)
At close: Apr 28, 2026, 4:00 PM EDT
23.50
-0.46 (-1.92%)
After-hours: Apr 28, 2026, 5:19 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $796.17 million as of April 28, 2026.
Market Cap
796.17M
Enterprise Value
584.62M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.96
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $796.17M, an increase of 157.84%. That is a compound annual growth rate of 199.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 835.71M | 260.44% |
| Dec 31, 2025 | 231.86M | -24.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 859.49M |
| MeiraGTx Holdings | 854.30M |
| Theravance Biopharma | 847.57M |
| MannKind | 833.75M |
| Arbutus Biopharma | 827.15M |
| ARS Pharmaceuticals | 823.17M |
| Kura Oncology | 821.94M |
| SELLAS Life Sciences Group | 800.94M |